ArticleAnnals of the rheumatic diseases2022

Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials.

Kevin L Winthrop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.